Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123945) titled 'Study on the Inhibitory Effect and Mechanism of the Novel Small Molecule Drug SGI-7079 on Inflammatory Responses in Gout' on May 3.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Suining Central Hospital
Condition:
Gout, a disease related to the activation of NLRP3 inflammasome
Intervention:
Case group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-04
Target Sample Size: Case group:5;Control group:5;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=318513
Disclaimer: Curated by ...